{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T03:16:17Z","timestamp":1787022977241,"version":"build-2736575974"},"reference-count":8,"publisher":"Centers for Disease Control MMWR Office","issue":"39","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["MMWR Morb. Mortal. Wkly. Rep."],"DOI":"10.15585\/mmwr.mm7039e4","type":"journal-article","created":{"date-parts":[[2021,9,28]],"date-time":"2021-09-28T10:02:16Z","timestamp":1632823336000},"page":"1379-1384","source":"Crossref","is-referenced-by-count":81,"title":["Safety Monitoring of an Additional Dose of COVID-19 Vaccine \u2014 United States, August 12\u2013September 19, 2021"],"prefix":"10.15585","volume":"70","author":[{"given":"Anne M.","family":"Hause","sequence":"first","affiliation":[{"name":"CDC COVID-19 Response Team."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Baggs","sequence":"additional","affiliation":[{"name":"CDC COVID-19 Response Team."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julianne","family":"Gee","sequence":"additional","affiliation":[{"name":"CDC COVID-19 Response Team."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paige","family":"Marquez","sequence":"additional","affiliation":[{"name":"CDC COVID-19 Response Team."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanya R.","family":"Myers","sequence":"additional","affiliation":[{"name":"CDC COVID-19 Response Team."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom T.","family":"Shimabukuro","sequence":"additional","affiliation":[{"name":"CDC COVID-19 Response Team."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David K.","family":"Shay","sequence":"additional","affiliation":[{"name":"CDC COVID-19 Response Team."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"6224","published-online":{"date-parts":[[2021,10,1]]},"reference":[{"key":"key-10.15585\/mmwr.mm7039e4-202109301011-R1","unstructured":"Food and Drug Administration. Pfizer-BioNTech COVID-19 vaccine letter of authorization. Silver Spring, MD: US Department of Health and Human Services, Food and Drug Administration; 2021. https:\/\/www.fda.gov\/media\/150386\/download"},{"key":"key-10.15585\/mmwr.mm7039e4-202109301011-R2","unstructured":"Food and Drug Administration. Moderna COVID-19 vaccine letter of authorization. Silver Spring, MD: US Department of Health and Human Services, Food and Drug Administration; 2021. https:\/\/www.fda.gov\/media\/144636\/download"},{"key":"key-10.15585\/mmwr.mm7039e4-202109301011-R3","unstructured":"Pfizer Inc. Pfizer and BioNTech initiate rolling submission of supplemental biologics license applications to U.S. FDA for booster dose of Comirnaty in individuals 16 and older. New York City, NY: Pfizer Inc.; 2021. https:\/\/www.pfizer.com\/news\/press-release\/press-release-detail\/pfizer-and-biontech-initiate-rolling-submission"},{"key":"key-10.15585\/mmwr.mm7039e4-202109301011-R4","doi-asserted-by":"publisher","first-page":"2201","DOI":"10.1001\/jama.2021.5374","article-title":"Reactogenicity following receipt of mRNA-based COVID-19 vaccines.","volume":"325","author":"Chapin-Bardales","year":"2021","journal-title":"JAMA"},{"key":"key-10.15585\/mmwr.mm7039e4-202109301011-R5","unstructured":"CDC. Interim clinical considerations for use of COVID-19 vaccines currently approved or authorized in the United States. Atlanta, GA: US Department of Health and Human Services, CDC; 2021. Accessed September 25, 2021. https:\/\/www.cdc.gov\/vaccines\/covid-19\/clinical-considerations\/covid-19-vaccines-us.html"},{"key":"key-10.15585\/mmwr.mm7039e4-202109301011-R6","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.15585\/mmwr.mm7031e2","article-title":"Outbreak of SARS-CoV-2 infections, including COVID-19 vaccine breakthrough infections, associated with large public gatherings\u2014Barnstable County, Massachusetts, July 2021.","volume":"70","author":"Brown","year":"2021","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key-10.15585\/mmwr.mm7039e4-202109301011-R7","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.15585\/mmwr.mm7034e4","article-title":"Effectiveness of COVID-19 vaccines in preventing SARS-CoV-2 infection among frontline workers before and during B.1.617.2 (Delta) variant predominance\u2014eight U.S. locations, December 2020\u2013August 2021.","volume":"70","author":"Fowlkes","year":"2021","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key-10.15585\/mmwr.mm7039e4-202109301011-R8","unstructured":"CDC. Booster shot. Atlanta, GA: US Department of Health and Human Services, CDC; 2021. Accessed September 25, 2021. https:\/\/www.cdc.gov\/coronavirus\/2019-ncov\/vaccines\/booster-shot.html"}],"container-title":["MMWR. Morbidity and Mortality Weekly Report"],"original-title":[],"deposited":{"date-parts":[[2021,9,30]],"date-time":"2021-09-30T11:00:34Z","timestamp":1632999634000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.cdc.gov\/mmwr\/volumes\/70\/wr\/mm7039e4.htm?s_cid=mm7039e4_w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,1]]},"references-count":8,"journal-issue":{"issue":"39","published-online":{"date-parts":[[2021,10,1]]}},"URL":"https:\/\/doi.org\/10.15585\/mmwr.mm7039e4","relation":{},"ISSN":["0149-2195","1545-861X"],"issn-type":[{"value":"0149-2195","type":"print"},{"value":"1545-861X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,10,1]]},"published":{"date-parts":[[2021,10,1]]}}}